Rival Hits MiMedx With $6.8M Breach, Trade Secrets Suit
Regenerative medicine company MiMedx Group Inc. used its acquisition of a distributor to steal clients and withhold commissions from rival Osiris Therapeutics Inc., according to a $6.8 million suit filed in...To view the full article, register now.
Already a subscriber? Click here to view full article